Results 291 to 300 of about 112,118 (358)

Submaximal 2‐day cardiopulmonary exercise testing to assess exercise capacity and post‐exertional symptom exacerbation in people with long COVID

Experimental Physiology, EarlyView.
Abstract Long COVID has a complex pathology and a heterogeneous symptom profile that impacts quality of life and functional status. Post‐exertional symptom exacerbation (PESE) affects one‐third of people living with long COVID, but the physiological basis of impaired physical function remains poorly understood. Sixty‐eight people (age (mean ± SD): 50 ± 
Callum Thomas, Nik Kudiersky, Paul Ansdell, Ruth E Ashton, Calum Brown, Thomas Bewick, Jack Carr, Emily Hume, Padraig Spillane, Elisa Pastorio, Rebecca Owen, Tom Maden‐Wilkinson, Ethan McNeil‐Angopa, Tom Parkington, Ross Arena, Cemal Ozemek, Federico Formenti, Sundar Kumar Veluswamy, Rachita Gururaj, Mark A. Faghy   +19 more
wiley   +1 more source

Use of artificial intelligence to predict outcomes in mild aortic valve stenosis. [PDF]

Eur Heart J Digit Health
Julakanti RR, Padang R, Scott CG, Dahl J, Al-Shakarchi NJ, Metzger C, Lanyado A, Jackson JI, Nkomo VT, Pellikka PA.   +9 more
europepmc   +1 more source

EuroSCORE II: Current limitations and physiological gaps in risk stratification

Experimental Physiology, EarlyView.
Abstract Risk stratification remains critical in cardiac surgery, enabling clinicians to predict adverse outcomes and guide perioperative management. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, introduced in 2011, incorporates 18 key variables to provide an evidence‐based approach to risk assessment.
Jing Yong Ng, Eu Fon Tan, Marsioleda Kemberi, Eduardo Urgesi, Matti Jubouri, Damian M. Bailey, Mohamad Bashir, Wael I. Awad   +7 more
wiley   +1 more source

Unveiling the Angiogenic Potential and Functional Decline of Valve Interstitial Cells During Calcific Aortic Valve Stenosis Progression. [PDF]

J Cell Mol Med
Blandinières A, Rossi E, Gendron N, Rancic J, Rosa M, Dupont A, Idelcadi S, Philippe A, Poitier B, Bièche I, Vacher S, Cholley B, Gaussem P, Susen S, Smadja DM.   +14 more
europepmc   +1 more source

The causative role of amyloidosis in the cardiac complications of Alzheimer's disease: a comprehensive systematic review

The Journal of Physiology, EarlyView.
Abstract figure legend Schematic illustration of the bidirectional causative link between cerebral amyloid‐beta (Aβ) angiopathy and cardiovascular disease in Alzheimer's disease (AD). Common cardiovascular risk factors like microvascular thrombosis, diabetes, atrial fibrillation, hypertension and atherosclerosis lead to cerebral hypoperfusion and ...
Samuel Parker, Andrew F. James, Svetlana Mastitskaya   +2 more
wiley   +1 more source

Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis. [PDF]

Eur Heart J
Li Z, Cheng S, Guo B, Ding L, Liang Y, Shen Y, Li J, Hu Y, Long T, Guo X, Ge J, Gao R, Pibarot P, Zhang B, Xu H, Clavel MA, Wu Y.   +16 more
europepmc   +1 more source

Advances in cardiac devices and bioelectronics augmented with artificial intelligence

The Journal of Physiology, EarlyView.
Abstract figure legend Interfaces between the human heart, diagnostic bioelectronics, artificial intelligence, and clinical care. From left to right: Human heart and biosensor interface; representative waveforms of common diagnostic bioelectronic sensing modalities.
Charles Stark, Eric Rytkin, Andrei Alexandru Mircea, Igor R. Efimov   +3 more
wiley   +1 more source

Computational modelling of the impact of anatomical changes on ECGs in left ventricular hypertrophy

The Journal of Physiology, EarlyView.
Abstract figure legend Eccentric and concentric left ventricular hypertrophy distinctly alter 12‐lead ECG signals. Eccentric hypertrophy predominantly increases voltages in the precordial leads, whereas concentric hypertrophy affects voltages across all leads in a variable manner.
Mohammadreza Kariman, Karli Gillette, Matthias A. F. Gsell, Anton J. Prassl, Gernot Plank, Christoph M. Augustin   +5 more
wiley   +1 more source

Role of Lipoprotein (A) in aortic valve stenosis: Novel disease mechanisms and emerging pharmacotherapeutic approaches. [PDF]

Int J Cardiol Heart Vasc
Khan MI, Zahir RS, Dominguez AC, Romeo FJ.   +3 more
europepmc   +1 more source